You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Clonidine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for clonidine and what is the scope of freedom to operate?

Clonidine is the generic ingredient in eleven branded drugs marketed by Tris Pharma Inc, Lavipharm, Actavis Labs Ut Inc, Difgen Pharms, Dr Reddys Labs Sa, Mylan Technologies, Athena, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, Xgen Pharms, Zydus Pharms, Mylan Institutional, Actavis Elizabeth, Ajanta Pharma Ltd, Amneal Pharms Ny, Chartwell Rx, Endo Operations, Jubilant Generics, Novast Labs, Somerset Theraps Llc, Xiamen Lp Pharm Co, Concordia Pharms Inc, Boehringer Ingelheim, Alembic Pharms Ltd, Am Therap, Aurobindo Pharma Ltd, Chartwell Molecules, Duramed Pharms Barr, Impax Labs, Interpharm, Par Pharm, Prinston Inc, Rising, Sun Pharm Inds Inc, Teva, Trupharma, Unichem, Warner Chilcott, Watson Labs, and Yung Shin Pharm, and is included in sixty-five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Clonidine has twenty-one patent family members in fourteen countries.

There are twenty-two drug master file entries for clonidine. Eight suppliers are listed for this compound.

Drug Prices for clonidine

See drug prices for clonidine

Drug Sales Revenue Trends for clonidine

See drug sales revenues for clonidine

Recent Clinical Trials for clonidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad Simón BolívarPhase 3
National Cancer Institute, EgyptN/A
Sollis Therapeutics, Inc.Phase 3

See all clonidine clinical trials

Pharmacology for clonidine
Medical Subject Heading (MeSH) Categories for clonidine

US Patents and Regulatory Information for clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Difgen Pharms CLONIDINE clonidine SYSTEM;TRANSDERMAL 076157-003 Aug 18, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 078099-001 Aug 27, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 202983-001 Apr 2, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070317-001 Jun 9, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Sa CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 210680-001 Apr 30, 2018 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Concordia Pharms Inc KAPVAY clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022331-004 Sep 28, 2010 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lavipharm CATAPRES-TTS-3 clonidine SYSTEM;TRANSDERMAL 018891-003 Oct 10, 1984 ⤷  Sign Up ⤷  Sign Up
Lavipharm CATAPRES-TTS-3 clonidine SYSTEM;TRANSDERMAL 018891-003 Oct 10, 1984 ⤷  Sign Up ⤷  Sign Up
Lavipharm CATAPRES-TTS-1 clonidine SYSTEM;TRANSDERMAL 018891-001 Oct 10, 1984 ⤷  Sign Up ⤷  Sign Up
Lavipharm CATAPRES-TTS-1 clonidine SYSTEM;TRANSDERMAL 018891-001 Oct 10, 1984 ⤷  Sign Up ⤷  Sign Up
Lavipharm CATAPRES-TTS-1 clonidine SYSTEM;TRANSDERMAL 018891-001 Oct 10, 1984 ⤷  Sign Up ⤷  Sign Up
Lavipharm CATAPRES-TTS-2 clonidine SYSTEM;TRANSDERMAL 018891-002 Oct 10, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for clonidine

Country Patent Number Title Estimated Expiration
China 101400343 Modified release formulations containing drug-ion exchange resin complexes ⤷  Sign Up
Australia 2007227569 Modified release formulations containing drug-ion exchange resin complexes ⤷  Sign Up
Spain 2378573 ⤷  Sign Up
Japan 2009530298 ⤷  Sign Up
Russian Federation 2008140944 КОМПОЗИЦИИ С МОДИФИЦИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ КОМПЛЕКСЫ ЛЕКАРСТВЕННОЕ ВЕЩЕСТВО-ИОНООБМЕННАЯ СМОЛА ⤷  Sign Up
Taiwan 200812649 Modified release formulations containing drug-ion exchange resin complexes ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.